Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.172
+0.003 (1.78%)
At close: Mar 9, 2026, 4:00 PM EDT
0.169
-0.004 (-2.03%)
After-hours: Mar 9, 2026, 5:23 PM EDT
Propanc Biopharma Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0.56 | 0.01 | 0.02 | 0.01 | 0 | 0 | Upgrade
|
| Cash & Short-Term Investments | 0.56 | 0.01 | 0.02 | 0.01 | 0 | 0 | Upgrade
|
| Cash Growth | 3735.42% | -42.67% | 109.86% | 147.04% | 80.36% | -96.64% | Upgrade
|
| Other Receivables | 0.02 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Receivables | 0.02 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Prepaid Expenses | 7.13 | 8.33 | - | 0.01 | 0.01 | - | Upgrade
|
| Other Current Assets | 0 | 0 | 0 | - | - | - | Upgrade
|
| Total Current Assets | 7.71 | 8.35 | 0.03 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Property, Plant & Equipment | 0.06 | 0.06 | 0.02 | 0.04 | 0.06 | 0 | Upgrade
|
| Long-Term Deferred Charges | - | 0.29 | 0.03 | - | - | - | Upgrade
|
| Other Long-Term Assets | 7.35 | 10.93 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Assets | 15.11 | 19.63 | 0.07 | 0.06 | 0.08 | 0.01 | Upgrade
|
| Accounts Payable | 0.96 | 1.25 | 1.21 | 0.97 | 0.94 | 1 | Upgrade
|
| Accrued Expenses | 1.73 | 2.35 | 1.53 | 1.21 | 0.94 | 1.31 | Upgrade
|
| Short-Term Debt | 0.59 | 1.56 | 0.87 | 0.51 | 0.98 | 0.68 | Upgrade
|
| Current Portion of Leases | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | - | Upgrade
|
| Other Current Liabilities | 0.32 | 0.4 | 0.16 | 0.45 | 0.18 | 0.09 | Upgrade
|
| Total Current Liabilities | 3.62 | 5.58 | 3.79 | 3.16 | 3.06 | 3.08 | Upgrade
|
| Long-Term Debt | - | 0.11 | 0.06 | - | - | - | Upgrade
|
| Long-Term Leases | 0.04 | 0.04 | - | 0.02 | 0.04 | - | Upgrade
|
| Total Liabilities | 3.66 | 5.73 | 3.85 | 3.18 | 3.11 | 3.08 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0.01 | 0 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 143.64 | 138.24 | 61.7 | 60.31 | 57.36 | 54.07 | Upgrade
|
| Retained Earnings | -134.48 | -125.62 | -66.7 | -64.68 | -61.56 | -58.2 | Upgrade
|
| Treasury Stock | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | Upgrade
|
| Comprehensive Income & Other | 1.33 | 1.32 | 1.27 | 1.29 | 1.21 | 1.09 | Upgrade
|
| Total Common Equity | 10.45 | 13.91 | -3.78 | -3.12 | -3.03 | -3.07 | Upgrade
|
| Shareholders' Equity | 11.45 | 13.91 | -3.78 | -3.12 | -3.02 | -3.07 | Upgrade
|
| Total Liabilities & Equity | 15.11 | 19.63 | 0.07 | 0.06 | 0.08 | 0.01 | Upgrade
|
| Total Debt | 0.65 | 1.73 | 0.95 | 0.55 | 1.04 | 0.68 | Upgrade
|
| Net Cash (Debt) | -0.09 | -1.71 | -0.93 | -0.54 | -1.04 | -0.68 | Upgrade
|
| Net Cash Per Share | -0.01 | -0.43 | - | - | - | - | Upgrade
|
| Filing Date Shares Outstanding | 15.09 | 12.81 | 0.01 | - | - | - | Upgrade
|
| Total Common Shares Outstanding | 13.45 | 11.61 | - | - | - | - | Upgrade
|
| Working Capital | 4.08 | 2.77 | -3.77 | -3.14 | -3.05 | -3.07 | Upgrade
|
| Book Value Per Share | 0.78 | 1.20 | - | - | - | - | Upgrade
|
| Tangible Book Value | 10.45 | 13.91 | -3.78 | -3.12 | -3.03 | -3.07 | Upgrade
|
| Tangible Book Value Per Share | 0.78 | 1.20 | - | - | - | - | Upgrade
|
| Machinery | 0.03 | - | - | 0.03 | 0.03 | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.